Leisure Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $617K | Hold |
7,701
| – | – | 0.22% | 94 |
|
|
2025
Q4 | $657K | Hold |
7,701
| – | – | 0.22% | 93 |
|
|
2025
Q3 | $599K | Hold |
7,701
| – | – | 0.21% | 94 |
|
|
2025
Q2 | $602K | Sell |
7,701
-267
| -3% | -$19.9K | 0.23% | 89 |
|
|
2025
Q1 | $578K | Sell |
7,968
-266
| -3% | -$19K | 0.24% | 91 |
|
|
2024
Q4 | $610K | Hold |
8,234
| – | – | 0.24% | 94 |
|
|
2024
Q3 | $543K | Sell |
8,234
-942
| -10% | -$68.4K | 0.23% | 101 |
|
|
2024
Q2 | $848K | Buy |
9,176
+270
| +3% | +$23.9K | 0.4% | 77 |
|
|
2024
Q1 | $851K | Sell |
8,906
-576
| -6% | -$48.4K | 0.43% | 78 |
|
|
2023
Q4 | $723K | Hold |
9,482
| – | – | 0.39% | 82 |
|
|
2023
Q3 | $657K | Sell |
9,482
-45
| -0.5% | -$3.62K | 0.38% | 84 |
|
|
2023
Q2 | $899K | Sell |
9,527
-793
| -8% | -$68.9K | 0.5% | 68 |
|
|
2023
Q1 | $854K | Hold |
10,320
| – | – | 0.49% | 68 |
|
|
2022
Q4 | $770K | Sell |
10,320
-135
| -1% | -$10.4K | 0.4% | 78 |
|
|
2022
Q3 | $864K | Buy |
10,455
+44
| +0.4% | +$4.23K | 0.52% | 65 |
|
|
2022
Q2 | $990K | Hold |
10,411
| – | – | 0.51% | 64 |
|
|
2022
Q1 | $1.23M | Sell |
10,411
-208
| -2% | -$23.3K | 0.62% | 56 |
|
|
2021
Q4 | $1.38M | Buy |
10,619
+600
| +6% | +$70K | 0.63% | 57 |
|
|
2021
Q3 | $1.13M | Hold |
10,019
| – | – | 0.61% | 56 |
|
|
2021
Q2 | $1.04M | Sell |
10,019
-302
| -3% | -$28.5K | 0.58% | 61 |
|
|
2021
Q1 | $863K | Hold |
10,321
| – | – | 0.52% | 68 |
|
|
2020
Q4 | $942K | Hold |
10,321
| – | – | 0.61% | 55 |
|
|
2020
Q3 | $824K | Sell |
10,321
-200
| -2% | -$15.6K | 0.62% | 60 |
|
|
2020
Q2 | $727K | Sell |
10,521
-1,005
| -9% | -$71.4K | 0.59% | 62 |
|
|
2020
Q1 | $725K | Buy |
11,526
+3,135
| +37% | +$226K | 0.7% | 53 |
|
|
2019
Q4 | $653K | Buy |
8,391
+69
| +0.8% | +$5.39K | 0.52% | 79 |
|
|
2019
Q3 | $610K | Sell |
8,322
-1,020
| -11% | -$71.7K | 0.51% | 80 |
|
|
2019
Q2 | $575K | Sell |
9,342
-582
| -6% | -$35.2K | 0.51% | 76 |
|
|
2019
Q1 | $633K | Sell |
9,924
-876
| -8% | -$50K | 0.53% | 70 |
|
|
2018
Q4 | $551K | Sell |
10,800
-1,239
| -10% | -$62.7K | 0.52% | 69 |
|
|
2018
Q3 | $699K | Sell |
12,039
-1,347
| -10% | -$65.9K | 0.57% | 56 |
|
|
2018
Q2 | $650K | Sell |
13,386
-9,327
| -41% | -$435K | 0.55% | 57 |
|
|
2018
Q1 | $1.06M | Sell |
22,713
-6,921
| -23% | -$301K | 0.93% | 35 |
|
|
2017
Q4 | $1.11M | Buy |
29,634
+465
| +2% | +$17.1K | 0.92% | 40 |
|
|
2017
Q3 | $1.06M | Buy |
+29,169
| New | +$1.11M | 0.93% | 41 |
|
Other funds holding EW
VCM
VPM
Leisure Capital Management's EW Position: Q1 2026 in Review
Leisure Capital Management held its Edwards Lifesciences (EW) position steady in Q1 2026 at 7,701 shares worth $617K. The position accounts for 0.22% of the portfolio, ranked #94.
Leisure Capital Management first reported a position in EW in Q3 2017 and has held it in 35 quarters since. The position peaked at $1.38M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Leisure Capital Management held 7,701 shares of Edwards Lifesciences worth $617K as of Q1 2026.
- Leisure Capital Management left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.22% of Leisure Capital Management's portfolio in Q1 2026, its #94 holding.
- Leisure Capital Management first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 35 quarters since.
- Leisure Capital Management's Edwards Lifesciences position peaked at $1.38M in Q4 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Leisure Capital Management's 13F filing for Q1 2026, filed 8 May 2026.